Snake Venom Peptides as Next-Generation Anticancer Candidates
Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor killing, selectivity, and potential for pioneering new cancer therapeutics.
Quick Facts
What This Study Found
Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor killing, selectivity, and potential for pioneering new cancer therapeutics.
Key Numbers
Review covers multiple snake species and their venom-derived peptides across various cancer types and mechanisms.
How They Did This
Methodology detailed in publication.
Why This Research Matters
Relevant to expanding peptide-based therapeutic applications.
The Bigger Picture
Contributes to the growing evidence for peptide therapeutics.
What This Study Doesn't Tell Us
Limitations in publication.
Questions This Raises
- ?Long-term implications?
- ?Comparison to existing evidence?
- ?Next research steps?
Trust & Context
- Key Stat:
- Key finding Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor kil
- Evidence Grade:
- Based on study design in publication.
- Study Age:
- Published in 2025.
- Original Title:
- Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies.
- Published In:
- Biochimica et biophysica acta. Reviews on cancer, 1880(6), 189479 (2025)
- Authors:
- Almeida, José R(3), Pinos-Tamayo, Edgar A, Mendes, Bruno(3), Robles-Loaiza, Alberto A, Syahputra, Rony Abdi, Oliveira, Ana Gabriela Silva, Ribeiro, Rosy Iara Maciel de A
- Database ID:
- RPEP-09885
Evidence Hierarchy
Summarizes existing research on a topic.
What do these levels mean? →Frequently Asked Questions
What does this mean?
Review of snake venom-derived peptides as anticancer candidates covers their mechanisms of tumor killing, selectivity, and potential for pioneering new cancer therapeutics.
How reliable?
Consult publication and healthcare provider.
Read More on RethinkPeptides
Cite This Study
https://rethinkpeptides.com/research/RPEP-09885APA
Almeida, José R; Pinos-Tamayo, Edgar A; Mendes, Bruno; Robles-Loaiza, Alberto A; Syahputra, Rony Abdi; Oliveira, Ana Gabriela Silva; Ribeiro, Rosy Iara Maciel de A. (2025). Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies.. Biochimica et biophysica acta. Reviews on cancer, 1880(6), 189479. https://doi.org/10.1016/j.bbcan.2025.189479
MLA
Almeida, José R, et al. "Snake venom-derived peptides as anticancer candidates: Pioneering next-generation therapies.." Biochimica et biophysica acta. Reviews on cancer, 2025. https://doi.org/10.1016/j.bbcan.2025.189479
RethinkPeptides
RethinkPeptides Research Database. "Snake venom-derived peptides as anticancer candidates: Pione..." RPEP-09885. Retrieved from https://rethinkpeptides.com/research/almeida-2025-snake-venomderived-peptides-as
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.